<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph base="SL34599" principles="no" id="IFRS02_47"><paranum>47</paranum><prolog><data name="standard_number" value="IFRS 2"/><data name="paranum" value="47"/></prolog><body><p id="IFRS02_P0165">If the entity has measured the <xref base="SL141007" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0249">fair value<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0119"/></ph></xref> of goods or services received as consideration for <xref base="SL140998" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0243">equity instruments<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0102"/></ph></xref> of the entity indirectly, by reference to the fair value of the <xref base="SL141001" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0245">equity instruments granted<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0103"/></ph></xref>, to give effect to the principle in <xref base="F2-173" href="IFRS02_46.dita#IFRS02_46" id="IFRS02_X0251">paragraph 46</xref>, the entity shall disclose at least the following: </p><ol base="SL140947" type="lower-alpha" id="IFRS02_L0014"><li id="IFRS02_47_a"><li_value>(a)</li_value>         <p base="SL140949" id="IFRS02_P0166">for <xref base="SL141034" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0290">share options<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0352"/></ph></xref> granted during the period, the weighted average fair value of those options at the <xref base="SL141019" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0264">measurement date<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0242"/></ph></xref> and information on how that fair value was measured, including:</p>         <ol base="SL140950" type="lower-roman" id="IFRS02_L0015"><li id="IFRS02_47_a_i"><li_value>(i)</li_value>             <p base="SL140952" id="IFRS02_P0167">the option pricing model used                              and the inputs                              to that model, including the weighted average share price, exercise price, expected volatility,                              option life, expected dividends,                              the risk&#x2011;free interest rate                              and any other inputs to the model,                              including the method used and the assumptions made to incorporate the effects of expected early exercise;                            </p>           </li><li id="IFRS02_47_a_ii"><li_value>(ii)</li_value>             <p base="SL140954" id="IFRS02_P0168">how expected volatility was determined, including an explanation of the extent to which expected volatility was based on historical volatility; and</p>           </li><li id="IFRS02_47_a_iii"><li_value>(iii)</li_value>             <p base="SL140956" id="IFRS02_P0169">whether and how any other features of the option grant were incorporated into the measurement of fair value, such as a <xref base="SL141016" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0254">market condition<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0236"/></ph></xref>.</p>           </li></ol>       </li><li id="IFRS02_47_b"><li_value>(b)</li_value>         <p base="SL140958" id="IFRS02_P0170">for other equity instruments granted during the period (ie other than share options), the number and weighted average fair value of those equity instruments at the measurement date, and information on how that fair value was measured,                      including:</p>         <ol base="SL140959" type="lower-roman" id="IFRS02_L0016"><li id="IFRS02_47_b_i"><li_value>(i)</li_value>             <p base="SL140961" id="IFRS02_P0171">if fair value was not measured on the basis of an observable market price, how it was determined;</p>           </li><li id="IFRS02_47_b_ii"><li_value>(ii)</li_value>             <p base="SL140963" id="IFRS02_P0172">whether and how expected dividends                              were incorporated into the measurement of fair value; and</p>           </li><li id="IFRS02_47_b_iii"><li_value>(iii)</li_value>             <p base="SL140965" id="IFRS02_P0173">whether and how any other features of the equity instruments granted were incorporated into the measurement of fair value.</p>           </li></ol>       </li><li id="IFRS02_47_c"><li_value>(c)</li_value>         <p base="SL140967" id="IFRS02_P0174">for<xref base="SL141028" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0282"> share&#x2011;based payment arrangements<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0350"/></ph></xref> that were modified during the period:                    </p>         <ol base="SL140968" type="lower-roman" id="IFRS02_L0017"><li id="IFRS02_47_c_i"><li_value>(i)</li_value>             <p base="SL140970" id="IFRS02_P0175">an explanation of those modifications;</p>           </li><li id="IFRS02_47_c_ii"><li_value>(ii)</li_value>             <p base="SL140972" id="IFRS02_P0176">the incremental fair value granted (as a result of those modifications); and</p>           </li><li id="IFRS02_47_c_iii"><li_value>(iii)</li_value>             <p base="SL140974" id="IFRS02_P0177">information on how the incremental fair value granted was measured, consistently with the requirements set out in (a) and (b) above, where applicable.</p>           </li></ol>       </li></ol></body></paragraph>